Go to the profile of ABL Bio

ABL Bio

 

About ABL Bio

ABL Bio is biotech research company focusing on the development of therapeutic drugs for immuno-oncology & neurodegenerative diseases. 1. Lead Molecule (ABL001): Bispecific antibody targeting VEGF and Dll4 (Phase 1, Q4, 2017) 2. ADC (Antibody Drug Conjugate) projects 3. T cell engaging Bispecific antibody 4. Immunooncology MoAb 5. Immunooncology Bispecific antibody 6. Synuclein targeting antibody with BBB-Crossing Trojan Horse Bispecific Antibody

Therapeutic Areas

Central Nervous System Oncology

Technologies

Other

Company Type

Biotechnology – Therapeutics

State of Ownership

Private

Sponsorship Group

Networker

Influencer Of

Topics

Editions participated in:

November 2017 September 2018